NCT07402018 Intra-aortic Balloon Counterpulsation (IABC) Compliance
| NCT ID | NCT07402018 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thomas Jefferson University |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2026-01-27 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators intend to study how baseline arterial compliance (as defined by stroke volume/pulse pressure) influences the clinical success of intraaortic balloon counterpulsation (IABC) in patients with cardiogenic shock (CS). The investigators aim to compare clinical outcomes in CS patients requiring IABC with normal compliance versus low compliance. The study will enroll patients undergoing IABC that are clinically indicated. Baseline hemodynamic measurements will be obtained and then patients would be stratified based on their compliance. Post IABC, serial hemodynamic measurements will be obtained and compared between groups. Patients will continue to be followed longitudinally until the IABC has been discontinued for any reason. The proposed study will yield results that will aid in developing a larger clinical trial and ultimately assist clinicians in determining if IABC is appropriate therapy for patients in cardiogenic shock.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old * Cardiogenic shock * Undergoing Intra-aortic Balloon Counterpulsation (IABC) as part of clinical care * Able to provide consent or have power of attorney or next of kin provide consent Exclusion Criteria: * Age \<18 years old * Unable to consent or does not have power of attorney or next of kin to consent
Contact & Investigator
Matthew S Delfiner, DO, MS
PRINCIPAL INVESTIGATOR
Thomas Jefferson University
Frequently Asked Questions
Who can join the NCT07402018 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07402018 currently recruiting?
Yes, NCT07402018 is actively recruiting participants. Contact the research team at elizabeth.westburg@jefferson.edu for enrollment information.
Where is the NCT07402018 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07402018 clinical trial?
NCT07402018 is sponsored by Thomas Jefferson University. The principal investigator is Matthew S Delfiner, DO, MS at Thomas Jefferson University. The trial plans to enroll 20 participants.